| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Lifitegrast |
|---|
| Description | Lifitegrast is a LFA-1 (lymphocyte function-associated antigen-1) antagonist intended for the treatment of vascular complications of the eye. Lifitegrast is a novel T-cell integrin antagonist that is designed to mimic the binding epitope of ICAM-1. It serves as a molecular decoy to block the binding of LFA-1/ICAM-1 and inhibits the downstream inflammatory process. MW: 615.48. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid; SAR-1118; SAR 1118; SAR1118; Lifitegrast, Xiidra. |
|---|
| Gene, Accession, CAS # | CAS: 1025967-78-5 |
|---|
| Catalog # | B1917-5 |
|---|
| Price | |
|---|
| Order / More Info | Lifitegrast from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|